Aperixaban Is Used To Treat Atrial Fibrillation Patients Who Are At Risk Of Stroke Caused By Blood Clots

Aperixaban
Aperixaban

The anticoagulant drug Apixaban, marketed under the trade name Eliquis, is used to treat and prevent blood clots as well as to prevent stroke in patients with nonvalvular atrial fibrillation by directly blocking factor Xa. In particular, it is used to avoid blood clots after hip or knee replacement surgery and in people with a history of clotting. 

It is used as an alternative to warfarin and doesn't call for dietary restrictions or blood tests for monitoring. It is consumed orally. Blood loss and nauseousness are frequent adverse effects. Bleeding around the spine and allergic reactions are possible additional adverse effects. Use is not suggested if nursing or pregnant. When used by people who have mild kidney issues, it seems to be relatively safe. It interacts with drugs less frequently than warfarin does. It directly inhibits factor Xa.

A blood clot that forms inside a vein can be treated with Apixaban Market, an anticoagulant that has been licenced by the Food and Drug Administration (FDA). Venous thromboembolic events (VTE) can happen suddenly and without any prior symptoms or warning signals, making them difficult for medical professionals to diagnose and recognise. When symptoms do manifest, they may be related to either a deep vein thrombosis (DVT) or a pulmonary embolism (PE), including chest pain, fast breathing, swelling in the ankle or foot, calf pain, and others.

The National Institute for Health and Clinical Excellence advises using Apixaban to prevent stroke and systemic embolism in adults with non-valvular atrial fibrillation with at least one of the risk factors listed below: age 75 or older, diabetes mellitus, or symptomatic heart failure. In patients with atrial fibrillation, apixaban and other anticoagulants (dabigatran, edoxaban, and rivaroxaban) appear to be just as effective as warfarin in avoiding non-hemorrhagic stroke and are linked to a decreased risk of intracranial bleeding.

Comments

Popular posts from this blog

Structure and Operation Principle of the Neuronavigation System: Applications and Trends

Innovation Unleashed: Exploring Valves' Limitless Possibilities

Creating a Connected Healthcare Ecosystem: Healthcare IT Consulting Strategies